{"id":"W1975807921","doi":"10.1097/jto.0b013e31827ce554","title":"A Randomized Phase 2 Study of Paclitaxel and Carboplatin with or without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer","year":2013,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"ca_institutions":"Regional Municipality of Durham","funders":"Universitair Ziekenhuis Gent; International Association for the Study of Lung Cancer; Amgen","keywords":"Medicine; Carboplatin; Neutropenia; Hazard ratio; Internal medicine; Lung cancer; Clinical endpoint; Confidence interval; Anemia; Paclitaxel; Placebo; Adverse effect; Performance status; Randomized controlled trial; Gastroenterology; Chemotherapy; Surgery; Cisplatin; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002170107,0.0001791619,0.001562216,0.0001547348,0.00004612399,0.000005384812,0.00004779169,0.00007167759,0.00007294594],"category_scores_gemma":[0.00006199999,0.00009273736,0.0001300365,0.0001063,0.00009908178,0.00007896396,0.000009994154,0.00008289581,1.563743e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002954521,"about_ca_system_score_gemma":0.0007487634,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004115571,"about_ca_topic_score_gemma":0.0005526023,"domain_scores_codex":[0.9987014,0.00009569091,0.0007371833,0.0001513433,0.0001548202,0.000159571],"domain_scores_gemma":[0.9974974,0.0005229542,0.001092448,0.00014149,0.0006094135,0.0001362921],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7394503,0.01982268,0.02056312,0.001001551,0.006655908,0.000179699,0.02323243,0.000557388,0.0037735,0.000005267533,0.0001735405,0.1845846],"study_design_scores_gemma":[0.883601,0.08563158,0.001669771,0.0004738073,0.01282224,0.0002242238,0.007670401,0.003033997,0.004126343,0.00003620854,0.0005539408,0.0001565547],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915731,0.002439974,0.0005606395,0.0007577593,0.000143123,0.004299972,0.00002844217,0.000004224488,0.0001927963],"genre_scores_gemma":[0.9901414,0.0006251477,0.007658935,0.00004401118,0.00008901131,0.0005689587,0.000005023561,0.00002160124,0.0008459259],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1844281,"threshold_uncertainty_score":0.378172,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02571052771314968,"score_gpt":0.4583277568896809,"score_spread":0.4326172291765312,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}